AB203. A randomized trial of trigone-including versus trigone-excluding intradetrusor injection of BTX-A for decreasing detrusor leak point pressure in patients with urinary incont...

por Hui, Chen, Huang, MP, Huang, JB, Liu, QL, Li, QQ, Huang, TH, Xie, Keji, Jiang, Chonghe
Publicado 2016

AB207. Combined detrusor and external urethral sphincter botulinum toxin A injections is a safe and effective treatment for decreasing leak point pressure in patients with incontin...

por Chen, Hui, Xie, Keji, Jiang, Chonghe, Huang, MP, Huang, JB, Liu, QL, Li, QQ, Huang, TH
Publicado 2016

AB204. Repeated intradetrusor botulinum toxin type A injections are still effective for patients with neurogenic detrusor overactivity secondary to spinal cord injury in China

por Chen, Hui, Yang, Xinghua, Zeng, Jingwen, Huang, Maping, Liu, Qiuling, Huang, Jiebing, Huang, Tianhai, Xie, Keji, Jiang, Chonghe
Publicado 2016

Cystitis glandularis: A controversial premalignant lesion

por YI, XIANLIN, LU, HAOYUAN, WU, YUEXIAN, SHEN, YANG, MENG, QINGGUI, CHENG, JIWENG, TANG, YONG, WU, FENGXUE, OU, RUBIAO, JIANG, SHAOJUN, BAI, XIANZHONG, XIE, KEJI
Publicado 2014

AB206. Combined detrusor-trigone BTX-A injections for urinary incontinence secondary to neurogenic detrusor overactivity

por Chen, Hui, Xie, Keji, Jiang, Chonghe, Tang, Ping, Ou, Rubiao, Zeng, Jianweng, Deng, Xiangrong, Zhou, Liling, Huang, Maping, Li, Qingqing, Liu, Qiuling, Huang, Jiebing, Huang, Tanghai
Publicado 2016

Tumor‐derived exosomal BCYRN1 activates WNT5A/VEGF‐C/VEGFR3 feedforward loop to drive lymphatic metastasis of bladder cancer

por Zheng, Hanhao, Chen, Changhao, Luo, Yuming, Yu, Min, He, Wang, An, Mingjie, Gao, Bowen, Kong, Yao, Ya, Yiyao, Lin, Yan, Li, Yuting, Xie, Keji, Huang, Jian, Lin, Tianxin
Publicado 2021

Muscarinic cholinergic signaling and overactive bladder-like symptoms associated with invasive bladder cancer

por Wei, Wei, Wang, Minggang, Li, Yunglong, Meng, Qinggui, Tang, Yong, Lu, Haoyuan, Yu, Wenchao, Cheng, Qiwei, Li, You, Xu, Long, Jian, Shaojun, Wu, Yuexian, Yi, Xianlin, Xie, Keji
Publicado 2018

Targeting WD repeat domain 5 enhances chemosensitivity and inhibits proliferation and programmed death-ligand 1 expression in bladder cancer

por Zhang, Jingtong, Zhou, Qianghua, Xie, Keji, Cheng, Liang, Peng, Shengmeng, Xie, Ruihui, Liu, Lixuan, Zhang, Yangjie, Dong, Wen, Han, Jinli, Huang, Ming, Chen, Yuelong, Lin, Tianxin, Huang, Jian, Chen, Xu
Publicado 2021

A phase 3, double-blind, randomized placebo-controlled efficacy and safety study of abiraterone acetate in chemotherapy-naïve patients with mCRPC in China, Malaysia, Thailand and R...

por Ye, Dingwei, Huang, Yiran, Zhou, Fangjian, Xie, Keji, Matveev, Vsevolod, Li, Changling, Alexeev, Boris, Tian, Ye, Qiu, Mingxing, Li, Hanzhong, Zhou, Tie, De Porre, Peter, Yu, Margaret, Naini, Vahid, Liang, Hongchuan, Wu, Zhuli, Sun, Yinghao
Publicado 2017

Hengli(®) Chinese Botulinum Toxin Type A for Treatment of Patients With Overactive Bladder: A Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled Trial

por Liao, Limin, Liu, Qinggang, Cong, Huiling, Xu, Zhihui, Li, Enhui, Weng, Zhiliang, Jiang, Haihong, Liu, Ben, Huang, Xiao, Xia, Shujie, Wen, Wei, Wu, Juan, Shi, Guowei, Wang, Yang, Li, Peijun, Yu, Yang, Fang, Zujun, Zheng, Jie, Tian, Ye, Shang, Donghao, Li, Hanzhong, Huang, Zhongming, Zhou, Liqun, Xiao, Yunxiang, Zhang, Yaoguang, Wang, Jianlong, Zhang, Xiaodong, Zhang, Peng, Wang, Dongwen, Zhang, Xuhui, Xie, Keji, Wang, Bin, Ma, Lulin, Tian, Xiaojun, Chen, Lijun, Dong, Jinkai
Publicado 2022